Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 11, 2014, Pages 4221-4226

  Wu, Wen Chao ^a   Sun, Hong Wei ^a   Chen, Hai Tian ^b   Liang, Jing ^b   Yu, Xing Juan ^a   Wu, Chong ^a   Wang, Zilian ^b   Zheng, Limin ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6;

ARTICLE; BONE MARROW; BREAST CARCINOMA; CANCER PATIENT; CELL DIFFERENTIATION; CELL TYPE; COLORECTAL CARCINOMA; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; GRANULOCYTE MONOCYTE PROGENITOR CELL; HEMATOPOIESIS; HEMATOPOIETIC STEM AND PROGENITOR CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MYELOID DERIVED SUPPRESSOR CELL; MYELOID PROGENITOR CELL; PRIORITY JOURNAL; SOLID TUMOR; STEM CELL; SUPPRESSOR CELL; TUMOR GROWTH; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIGENS, CD34; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MYELOID CELLS; NEOPLASMS; STEM CELLS;

EID: 84896521759     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1320753111     Document Type: Article

References (35)

1. Kondo M, et al. (2003) Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol 21:759-806. (Pubitemid 37174547)
2. Laiosa CV, Stadtfeld M, Graf T (2006) Determinants of lymphoid-myeloid lineage diversification. Annu Rev Immunol 24:705-738.
3. Essers MA, et al. (2009) IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458(7240):904-908.
4. King KY, Goodell MA (2011) Inflammatory modulation of HSCs: Viewing the HSC as a foundation for the immune response. Nat Rev Immunol 11(10):685-692.
5. Doulatov S, Notta F, Laurenti E, Dick JE (2012) Hematopoiesis: A human perspective. Cell Stem Cell 10(2):120-136.
6. Nagai Y, et al. (2006) Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24(6):801-812. (Pubitemid 43867369)
7. Rieger MA, Hoppe PS, Smejkal BM, Eitelhuber AC, Schroeder T (2009) Hematopoietic cytokines can instruct lineage choice. Science 325(5937):217-218.
8. Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9(3):162-174.
9. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12(4):253-268.
10. Serafini P, Mgebroff S, Noonan K, Borrello I (2008) Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res 68(13):5439-5449.
11. Cui TX, et al. (2013) Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. Immunity 39(3): 611-621.
12. Marigo I, et al. (2010) Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 32(6):790-802.
13. Corzo CA, et al. (2010) HIF-1α regulates function and differentiation of myeloidderived suppressor cells in the tumor microenvironment. J ExpMed 207(11):2439-2453.
14. Solito S, et al. (2011) A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood 118(8): 2254-2265.
15. Katsumata N, et al. (1996) Serum levels of cytokines in patients with untreated primary lung cancer. Clin Cancer Res 2(3):553-559. (Pubitemid 26099175)
16. Pang XH, et al. (2011) Preoperative levels of serum interleukin-6 in patients with hepatocellular carcinoma. Hepatogastroenterology 58(110-111):1687-1693.
17. Weissman IL, Shizuru JA (2008) The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood 112(9):3543-3553.
18. Pang WW, et al. (2011) Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci USA 108(50): 20012-20017.
19. Arndt K, et al. (2013) CD133 is a modifier of hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cells. Proc Natl Acad Sci USA 110(14):5582-5587.
20. Dar A, Kollet O, Lapidot T (2006) Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol 34(8):967-975. (Pubitemid 44080383)
21. Youn JI, et al. (2013) Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nat Immunol 14(3):211-220.
22. Ma G, et al. (2011) Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity 34(3):385-395.
23. Zou W, Chen L (2008) Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol 8(6):467-477. (Pubitemid 351733418)
24. Kuang DM, et al. (2008) Tumor-educated tolerogenic dendritic cells induce CD3epsilon down-regulation and apoptosis of T cells through oxygen-dependent pathways. J Immunol 181(5):3089-3098.
25. Nagaraj S, Gabrilovich DI (2010) Myeloid-derived suppressor cells in human cancer. Cancer J 16(4):348-353.
26. Wynn TA, Chawla A, Pollard JW (2013) Macrophage biology in development, homeostasis and disease. Nature 496(7446):445-455.
27. Gajewski TF, Schreiber H, Fu YX (2013) Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 14(10):1014-1022.
28. Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1):39-51.
29. Jin L, et al. (2009) Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells. Cell Stem Cell 5(1): 31-42.
30. Testa U, et al. (2004) Interleukin-3 receptor in acute leukemia. Leukemia 18(2): 219-226. (Pubitemid 38240035)
31. Griseri T, McKenzie BS, Schiering C, Powrie F (2012) Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation. Immunity 37(6):1116-1129.
32. Cortez-Retamozo V, et al. (2012) Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci USA 109(7):2491-2496.
33. Jung MR, et al. (2011) Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol 104(5): 504-510.
34. Movahedi K, et al. (2008) Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111(8): 4233-4244.
35. Gallina G, et al. (2006) Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 116(10):2777-2790. (Pubitemid 44511641)